Clinical Trial Update: A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase Ib/II study evaluating HH-009 for FGF19-positive advanced or unresectable hepatocellular carcinoma, focusing on eff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• HH-009

Snippet

Sponsor: Huahui Health | Conditions: Advanced or Unresectable Hepatocellular Carcinoma (HCC) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING